IPP Bureau
Japan approves AstraZeneca’s Forxiga for chronic kidney disease
By IPP Bureau - August 28, 2021
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
Marksans announces US FDA approval for Acetaminophen Extended- Release tablets
By IPP Bureau - August 27, 2021
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
Aurobindo subsidiary, Eugia gets US FDA approval for Cyclophosphamide injection
By IPP Bureau - August 27, 2021
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Rajasthan installs its first oxygen plant in Sikar
By IPP Bureau - August 27, 2021
To prevent the state from facing a shortage of medical oxygen and to bolster the existing infrastructure, the SRAM & MRAM group is actively helping the state government to set up oxygen plants in multiple cities
Krsnaa Diagnostics to operate centres across Punjab
By IPP Bureau - August 27, 2021
First diagnostic centre to open in Mohali on August 31
SEC recommends Phase I clinical trials for Reliance’s Covid-19 vaccine candidate
By IPP Bureau - August 27, 2021
The company has to approach the DCGI for approval to commence the trials
Indoco’s AnaCipher receives UK-MHRA accreditation
By IPP Bureau - August 27, 2021
The clinical research organisation located in Hyderabad is a USFDA inspected facility
Brazil’s Eurofarma to manufacture Comirnaty for Latin America
By IPP Bureau - August 27, 2021
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Pharma continues to attract PE investments: Care Ratings
By IPP Bureau - August 27, 2021
In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020
Johnson & Johnson booster dose indicate impressive results
By IPP Bureau - August 26, 2021
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
Pfizer and BioNTech initiate rolling submission for Comirnaty booster dose
By IPP Bureau - August 26, 2021
The submission to the US FDA has been initiated and they intend to file these data with the European Medicines Agency and other regulatory bodies in the coming weeks
Doctors at MGM Healthcare perform complex bilateral lung transplant
By IPP Bureau - August 26, 2021
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
Adjuvance announce clinical results of its next-gen saponin adjuvant
By IPP Bureau - August 26, 2021
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
By IPP Bureau - August 26, 2021
The company to receive upfront and milestone payments, in addition to royalties
Merck donates Rs 1.7 crore to IIT Bombay for Covid-19 research
By IPP Bureau - August 26, 2021
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
